Table 1.
Antigen | Antigen function | Tumour association | Syndromes | Mechanisms | Prognosis |
---|---|---|---|---|---|
Hu proteins (primarily HuD, but also HuC, Hel-N1 and Hel-N2)112 | HuD is important for neuronal RNA handling, cell-cycle regulation and cell development113,114 | Small-cell lung cancer115 | Neuropathy (often purely sensory), cerebellitis, limbic encephalitis, autonomic dysfunction and/or brainstem encephalitis | Antibodies are not directly pathogenic; possibly T-cell-mediated | 20% survival at 3 years (encephalitis is slightly more likely to cause death than is cancer) |
Collapsin response mediator protein 5 | Regulation of neurite outgrowth, and neurogenesis116 | Small-cell lung cancer and thymoma117 | Neuropathy, uveoretinal symptoms, ataxia or limbic encephalitis117 | Possibly T-cell-mediated22 | Longer survival than with anti-Hu syndromes (48 versus 11 months)117 |
Ma1118 | Promotion of apoptosis | Diverse (lung, skin, gastrointestinal and renal) | Limbic encephalitis, cerebellitis, brainstem encephalitis or polyneuropathy | Probably T-cell-mediated rather than antibody-mediated21 | In a series of 13 patients, nine deteriorated, three stabilized and one improved119 |
Ma2 (also known as Ta)118 | Not known | Germ cell tumours (especially in young men) | Limbic encephalitis, brainstem encephalitis, polyneuropathy or cerebellitis119 | Not known | In a case series 33% improved, 21% stabilized and 46% deteriorated119 |
Yo proteins (also known CDR1 and CDR2) | CDR1 is strongly expressed in Purkinje cells; function unknown120 CDR2 may be involved in cell cycle regulation, mitosis, and transcriptional regulation121 | Specific to women Almost all are eventually diagnosed with breast or gynaecological cancer122 | Paraneoplastic cerebellar degeneration | Conflicting data in patients regarding a role for T cells27,28 Antibodies trigger neuronal cell death in slice culture29 | Tumours may respond, but neurological symptoms are often unresponsive122 |
Ri proteins (also known as Nova-1 and Nova-2) | Nova-1 is an RNA-binding protein expressed by subcortical neurons Function of Nova-2 is not known | Breast cancer | Nova-1: cerebellar degeneration, encephalitis, myelitis, opsoclonus myoclonus123,124 Nova-2: paraneoplastic opsoclonus myoclonus ataxia,125 myoclonus, encephalitis, cerebellar degeneration and myelitis | Antibodies may prevent binding of Nova-1 to RNA126 Unclear whether antibodies are pathogenic; comorbid antibodies are common and can occur in asymptomatic cancer patients127 | Three of six patients improved; median survival >69 months in one series123 |
Tr | Found in Purkinje neurons;128 function not known | Hodgkin lymphoma | Paraneoplastic cerebellar degeneration129 | Not known | Relatively good: median survival >113 months123 |
Zinc finger protein ZIC 4 | Important for brain development | Small-cell lung cancer | Paraneoplastic cerebellar degeneration130 | Antibodies may not be pathogenic; 80% of patients have other antibodies as well | Not known |
Gephyrin and GABARAP | Associated with GABAergic transmission | Gephyrin: mediastinal carcinoma GABARAP: not known | Stiff-person syndrome131,132 | Not known | Not known |
Abbreviations: GABA, γ-aminobutyric acid; GABARAP, GABA receptor-associated protein.